Methylphenidate for apathy and functional status in dementia of the Alzheimer type.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  The American journal of geriatric psychiatry

• Publication date

  2010-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/JGP.0b013e3181cabcf6PMID 20220576
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methylphenidate for the Treatment of Apathy in Alzheimer Disease: Prediction of Response Using Dextroamphetamine Challenge

  2008cited by this paper
• Toward Individualized Evidence‐Based Medicine: Five “N of 1” Trials of Methylphenidate in Geriatric Patients

  2001cited by this paper
• Methylphenidate treatment of negative symptoms in patients with dementia.

  1997cited by this paper
• J Neuropsychiatry Clin Neurosci

  1992cited by this paper
• A Prospective Evaluation of the Geriatric Depression Scale in an Outpatient Geriatric Assessment Center

  1992cited by this paper
• Functional status and clinical findings in patients with Alzheimer's disease.

  1992cited by this paper
• Reliability and validity of the Apathy Evaluation Scale.

  1991cited by this paper
• Apathy: a neuropsychiatric syndrome.

  1991cited by this paper
• Differential diagnosis and classification of apathy.

  1990cited by this paper
• Development and validation of a geriatric depression screening scale: a preliminary report.

  1982cited by this paper
• Assessment of older people: self-maintaining and instrumental activities of daily living.

  1969cited by this paper

• Apathy in dementia: pharmacological and nonpharmacological treatment strategies.

  2025cites this paper
• From Lab to Clinic: Success Stories of Repurposed Drugs in Treating Major Diseases

  2025cites this paper
• The treatment of behavioural and psychological symptoms in dementia: pragmatic recommendations

  2024cites this paper
• Reversal of the motivational effects of tetrabenazine by NMDA receptor blockade.

  2024cites this paper
• Apathy in Alzheimer's disease: A Neurocircuitry Based Perspective.

  2023cites this paper
• Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study

  2023cites this paper
• Promising candidates from drug clinical trials: Implications for clinical treatment of Alzheimer's disease in China

  2022cites this paper
• Ninjin'yoeito, a traditional Japanese medicine, increases dopamine content in PC12 cells.

  2021cites this paper
• A Brief Review of Alzheimer’s Disease

  2021cites this paper
• Methylphenidate for Mild Cognitive Impairment: An Exploratory 3-Day, Randomized, Double-Blind, Placebo-Controlled Trial

  2021cites this paper
• Amphetamine Use in the Elderly: A Systematic Review of the Literature

  2020cites this paper
• Neuroanatomical Abnormalities in Older Depressed Adults With Apathy: A Systematic Review

  2020cites this paper
• NDT_A_277740 2677..2680

  2020cites this paper
• Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer’s Patients Treated with Donepezil: Case Series

  2020cites this paper
• The therapeutic effects of methylphenidate and matrix-methylphenidate on addiction severity, craving, relapse and mental health in the methamphetamine use disorder

  2020cites this paper
• Neuromodulation for Apathy in Alzheimer’s Disease: A Double-Blind, Randomized, Sham-Controlled Pilot Study

  2020cites this paper
• A cross sectional study

  2020cites this paper
• Selective serotonin reuptake inhibitors-associated apathy syndrome

  2020cites this paper
• Treating Apathy in Late-Life Depression.

  2020cites this paper
• Neuropsychiatric Aspects of Alzheimer Dementia: From Mechanism to Treatment.

  2020cites this paper
• Methylphenidate and galantamine in patients with vascular cognitive impairment–the proof-of-principle study STREAM-VCI

  2020cites this paper
• Serotonergic system, cognition, and BPSD in Alzheimer's disease.

  2019cites this paper
• Major Neurocognitive Disorder with Behavioral Disturbance (Behavioral and Psychological Symptoms of Dementia—BPSD)

  2019cites this paper
• A Case Series: Adjunctive Treatment of Major Depressive Disorder in the Geriatric Population with the Methylphenidate Patch

  2019cites this paper
• Unmet Needs in Pharmacological Treatment of Apathy in Alzheimer’s Disease: A Systematic Review

  2019cites this paper
• Is Methylphenidate Effective in Reducing Apathy among Alzheimer’s Disease Patients?

  2019influential citation
• Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia.

  2019cites this paper
• Current Agents in Development for Treating Behavioral and Psychological Symptoms Associated with Dementia

  2019cites this paper
• [The efficacy of pharmacological approaches to therapy of the apathy syndrome in dementia disorders (the review)].

  2018cites this paper
• Repetitive transcranial magnetic stimulation for apathy in mild cognitive impairment: A double-blind, randomized, sham-controlled, cross-over pilot study

  2018cites this paper
• Symptomatic Treatment of Vascular Cognitive Impairment (STREAM-VCI): Protocol for a Cross-Over Trial

  2018influential citation
• Methylphenidate Treatment for Patients With Posterior Cortical Atrophy.

  2018cites this paper
• Cognition and apathy in normal pressure hydrocephalus

  2018cites this paper
• Behavioral Symptoms of Dementia

  2018cites this paper
• Visual Scanning and Attentional Biases in Alzheimerâ s Disease: Assessing Symptoms and Outcomes

  2017influential citation
• Apathy associated with neurocognitive disorders: Recent progress and future directions

  2017influential citation
• Pharmacological and Nonpharmacological Treatment for Apathy in Alzheimer Disease

  2017cites this paper
• Apathy in Parkinson's Disease.

  2017cites this paper
• Pharmacological Therapy for Apathy in Alzheimer’s Disease: A Systematic Review and Meta-Analysis

  2017cites this paper
• Methylphenidat bei einem M.‑Alzheimer-Patienten

  2017cites this paper
• Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT

  2016cites this paper
• G-protein coupled receptors as therapeutic targets for neurodegenerative and cerebrovascular diseases.

  2016cites this paper
• Pharmacotherapy of Dementia

  2016influential citation
• The role of dopamine in the pathophysiology and treatment of apathy.

  2016cites this paper
• Apathy and Attentional Biases in Alzheimer’s Disease

  2016cites this paper
• Psychiatric and Medical Comorbidity in the Primary Care Geriatric Patient—An Update

  2016cites this paper
• Effects of methylphenidate on the behavior of male 5xFAD mice.

  2015cites this paper
• Aripiprazole for Treatment of Apathy.

  2015cites this paper
• Methylphenidate prolongs symptom-free period of experimental prion disease in mice.

  2015cites this paper
• Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia

  2015cites this paper
• Catecholamine-Based Treatment in AD Patients: Expectations and Delusions

  2015cites this paper
• Neurobiological basis of motivational deficits in psychopathology.

  2015cites this paper
• Attention enhancing effects of methylphenidate are age-dependent.

  2015cites this paper
• Apathy in Neurodegenerative Diseases

  2015cites this paper
• Quantifying motivational deficits and apathy: a review of the literature.

  2015cites this paper
• Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?

  2015cites this paper
• A Review of Pharmacological Treatments for Depression in Alzheimer's Disease.

  2015cites this paper
• Neuropsychiatric Syndromes in the Survivors of Traumatic Brain Injury in Oman: An examination of disorder of self-neglect

  2015cites this paper
• The role of methylphenidate in depression

  2015cites this paper
• Depression

  2015cites this paper
• Apathy in Neurodegenerative Diseases: Recommendations on the Design of Clinical Trials

  2015cites this paper
• Therapeutics of Alzheimer's disease: Past, present and future.

  2014cites this paper
• Considerations in psychotropic treatments in dementia--can polypharmacy be avoided?

  2014cites this paper
• The effects of methylphenidate on whole brain intrinsic functional connectivity

  2014influential citation
• Effects of a non-focal plasticity protocol on apathy in moderate Alzheimer's disease: a randomized, double-blind, sham-controlled trial.

  2014cites this paper
• olecular imaging of neuropsychiatric symptoms in Alzheimer ’ s and arkinson ’ s disease

  2014cites this paper
• Apathy in Alzheimer's Disease: Any Effective Treatment?

  2014cites this paper
• Neuropsychiatric Symptoms in Patients with Dementias Associated with Cortical Lewy Bodies: Pathophysiology, Clinical Features, and Pharmacological Management

  2013cites this paper
• Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial

  2013cites this paper
• Pharmacological treatment of behavioral and emotional symptoms of Alzheimer’s disease: a case for polypharmacy

  2013cites this paper
• Effect of Methylphenidate on Attention in Apathetic Alzheimer’s Disease Patients and Association with Apathy Changes in a Randomized, Placebo-controlled Trial

  2013cites this paper
• Clinical update on nursing home medicine: 2012.

  2012cites this paper
• A randomized, double-blind, placebo-controlled trial of modafinil for the treatment of apathy in individuals with mild-to-moderate Alzheimer's disease.

  2012cites this paper
• Attention-Deficit/Hyperactivity Disorder in Older Adults: Prevalence and Possible Connections to Mild Cognitive Impairment

  2012cites this paper
• Histamine and motivation

  2012cites this paper
• Apathy Syndrome in Alzheimer's Disease Epidemiology: Prevalence, Incidence, Persistence, and Risk and Mortality Factors

  2012cites this paper
• Validation of Physician Orders for Life‐Sustaining Treatment: Electronic Registry to Guide Emergency Care

  2012cites this paper
• Apathy: prevalence, associated factors, and prognostic value among frail, older inpatients.

  2012cites this paper
• Reversal of SSRI-Associated Apathy Syndrome by Discontinuation of Therapy

  2012cites this paper
• Improvement of Glycemic Control Using Methylphenidate Treatment of Apathy: A Preliminary Report

  2012cites this paper
• Perspectives Neuropsychiatric symptoms in Alzheimer's disease

  2011cites this paper
• An update on the neuropsychiatric symptoms of dementia

  2011cites this paper
• Therapeutics of Alzheimer’s Disease

  2011cites this paper
• Managing apathy.

  2011cites this paper
• Neuropsychiatric symptoms in Alzheimer's disease

  2011cites this paper
• Patterns of Methylphenidate Use and Assessment of its Abuse and Diversion in Two French Administrative Areas Using a Proxy of Deviant Behaviour Determined from a Reimbursement Database

  2011cites this paper
• Treatment of Apathy in Huntington’s Disease and Other Movement Disorders

  2011cites this paper
• Apathy in Neuropsychiatric Disease: Diagnosis, Pathophysiology, and Treatment

  2011influential citation
• The Role of Dopamine in Symptoms and Treatment of Apathy in Alzheimer's Disease

  2011cites this paper
• Use of Psychostimulants in Patients with Dementia

  2010cites this paper
• Are You Motivated to Treat Apathy

  2010cites this paper
• Effect of chronic treatment of carvedilol on oxidative stress in an intracerebroventricular streptozotocin induced model of dementia in rats

  2009cites this paper